Controversies in translational research: Drug self-administration

Psychopharmacology

Volumn 199, Issue 3, 2008, Pages 403-419

  Haney, Margaret ^a   Spealman, Roger ^b  

^a Columbia University ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cocaine; Dopamine receptor; Drug abuse; Human; Model; Monkey; Naloxone; Opioid; Reinforcement

Indexed keywords

ARIPIPRAZOLE; BUPRENORPHINE; COCAINE; DIAMORPHINE; ECOPIPAM; METHADONE; MODAFINIL; MORPHINE; NALOXONE; NALTREXONE; OPIATE; PARTIAL AGONIST;

BEHAVIOR DISORDER; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTINUOUS INFUSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FALSE POSITIVE RESULT; HEROIN DEPENDENCE; HUMAN; LOW DRUG DOSE; MEDICAL RESEARCH; NONHUMAN; OPIATE ADDICTION; PATIENT COMPLIANCE; PREDICTIVE VALIDITY; PRIMATE; PRIORITY JOURNAL; REINFORCEMENT; RELIABILITY; REVIEW; RODENT; TREATMENT OUTCOME;

ANIMALS; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; HEROIN DEPENDENCE; HUMANS; PRIMATES; RODENTIA; SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS;

EID: 46649114376     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1079-x     Document Type: Review

References (181)

1. Aceto MD (1984) Characterization of prototypical opioid antagonists, agonist-antagonists, and agonists in the morphine-dependent rhesus monkey. Neuropeptides 5:15-18
2. Ahmed SH (2005) Imbalance between drug and non-drug reward availability: a major risk factor for addiction. Eur J Pharmacol 526:9-20
3. Alho H, Sinclair D, Vuori E, Holopainen A (2007) Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 88:75-78
4. Altman JL, Meyer RE, Mirin SM, McNamee HB (1976) Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study. Int J Addict 11:485-499
5. Balster RL (1991) Drug abuse potential evaluation in animals. Br J Addict 86:1549-1558
6. Barone P, Tucci I, Parashos SA, Chase TN (1988) Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade. Eur J Pharmacol 49:225-232
7. Bergman J, Madras BK, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155
8. Bergman J, Kamien JB, Spealman RD (1990) Antagonism of cocaine self-administration by selective dopamine D(1) and D(2) antagonists. Behav Pharmacol 1:355-363
9. Bertalmio AJ, Woods JH (1989) Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis. J Pharmacol Exp Ther 251:455-460
10. Bigelow GE, Walsh SL (1998) Evaluation of potential pharmacotherapies: response to cocaine challenge in the human laboratory. In: Higgins ST, Katz JL (eds) Cocaine abuse: behavior, pharmacology, and clinical applications. Elsevier, Amsterdam, pp 209-238
11. Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV (2006) A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend 81:267-274
12. Blumberg H, Dayton HB (1974) Naloxone, naltrexone, and related noroxymorphones. Adv Biochem Psychopharmacol 8:33-43
13. Brady JV, Griffiths RR, Hienz RD, Ator NA, Lukas SE, Lamb RJ (1987) Assessing drugs for abuse liability and dependence potential in laboratory primates. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, Berlin, pp 45-86
14. Braun AR, Laruelle M, Mouradian MM (1997) Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. J Neural Transm 104:341-362
15. Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209-218
16. Campbell UC, Carroll ME (2000) Reduction of drug self-administration by an alternative non drug reinforcer in rhesus monkeys: magnitude and temporal effects. Psychopharmacology 147:418-425
17. Campbell UC, Lac ST, Carroll ME (1999) Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143:209-214
18. Campbell J, Nickel E, Penick EC, Wallace D, Gabrielle WF, Rowe C, Liskow B, Powell BJ, Thomas HM (2003) Comparison of desipramine or carbamezepine to placebo for crack cocaine-dependent patients. Am J Addict 12:122-136
19. Capone R, Brahen L, Condren R, Kordal N, Melchionda R, Peterson M (1986) Retention and outcome in a narcotic antagonist treatment program. J Clin Psychol 42:825-833
20. Chen SA, O'Dell LE, Hoefer ME, Greenwell TN, Zorrilla EP, Koob GF (2006) Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology 31:2692-2707
21. Ciraulo DA, Sarid-Segal O, Knapp CM, Ciraulo AM, LoCastro J, Bloch DA, Montgomery MA, Leiderman DB, Elkashef A (2005) Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. Addiction 100:12-22
22. Collins ED, Vosburg SK, Hart CL, Haney M, Foltin RW (2003) Amantadine does not modulate reinforcing, subjective, or cardiovascular effects of cocaine in humans. Pharmacol Biochem Behav 76:401-407
23. Comer SD, Collins ED (2002) Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers. J Pharmacol Exp Ther 303:695-703
24. Comer SD, Collins ED, Fischman MW (1997) Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol 8:677-690
25. Comer SD, Collins ED, Wilson ST, Donovan MR, Foltin RW, Fischman MW (1998) Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Euro J Pharmacol 345:13-26
26. Comer SD, Collins ED, MacArthur RB, Fischman MW (1999) Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology 143:327-338
27. Comer SD, Collins ED, Fischman MW (2001) Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans. Psychopharmacology 154:28-37
28. Comer SD, Collins ED, Fischman MW (2002a) Intravenous buprenorphine self-administration by detoxified heroin abusers. J Pharmacol Exp Ther 301:266-276
29. Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW (2002b) Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology 159:351-360
30. Comer SD, Walker EA, Collins ED (2005) Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers. Psychopharmacology 181:664-675
31. Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP (2006) Injectable, sustained-release naltrexone for the treatment of opioid dependence. Arch Gen Psychiatry 63:210-218
32. Comer SD, Ashworth JB, Foltin RW, Johanson C-E, Zacny JP, Walsh SD (2008a) The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend (in press)
33. Comer SD, Sullivan MA, Whittington RA, Vosburg SK, Kowalczyk WJ (2008b) Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology (in press) DOI 10.1038/sj.npp.1301479
34. Corrigall WA, Coen KM (1989) Fixed-interval schedules for drug self-administration in the rat. Psychopharmacology 99:136-139
35. Creese I, Chen A (1985) Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390. Eur J Pharmacol 109:127-128
36. Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW, Rowan A, Poole S, White L, O'Brien CP (2003) Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70:29-37
37. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30:205-211
38. de Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M (2002) Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97:931-949
39. Deneau GA, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmaolcogia 61:30-48
40. Depoortere RY, Li DH, Lane JD, Emmett-Oglesby MW (1993) Parameters of self-administration of cocaine in rats under a progressive-ratio schedule. Pharmacol Biochem Behav 45:539-548
41. Deroche-Gamonet V, Darnaudéry M, Bruins-Slot L, Piat F, Le Moal M, Piazza PV (2002) Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology 161:387-395
42. Dole VP, Nyswander ME (1965) A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA 193:80-84
43. Donny EC, Bigelow GE, Walsh SL (2003) Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement. Drug Alcohol Depend 69:289-301
44. Donny EC, Bigelow GE, Walsh SL (2004) Assessing the initiation of cocaine self-administration in humans during abstinence: effects of dose, alternative reinforcement, and priming. Psychopharmacology 172:316-323
45. Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL (2005) Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction 100:1496-1509
46. Donovan JL, DeVane CL, Malcolm RJ, Mojsiak J, Chiang CN, Elkashef A, Taylor RM (2005) Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers. Clin Pharmacokinet 44:753-765
47. Dudish-Poulsen SA, Hatsukami DK (1997) Dissociation between subjective and behavioral responses after cocaine stimuli presentations. Drug Alcohol Depend 47:1-9
48. Elkashef A, Fudala PJ, Gorgon L, Li SH, Kahn R, Chiang N, Vocci F, Collins J, Jones K, Boardman K, Sather M (2006) Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence. Drug Alcohol Depend 85:191-197
49. Emmett-Oglesby M, Mathis D (1988) Chronic administration of SCH 23390 produces sensitization to the discriminative stimulus properties of cocaine. In: Harris LS (ed) Problems of drug dependence. Proceedings of the 50th Annual Scientific Meeting, The College on Problems of Drug Dependence. United States Department of Health and Human Services, Rockville, MD, p 367
50. Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204-209
51. Everitt BJ, Robbins TW (2000) Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology 153:17-30
52. Feltenstein MW, Altar CA, See RE (2007) Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. Biol Psychiatry 61:582-590
53. Ferraro L, Antonelli T, Tanganelli S, O'Connor WT, Perez de la Mora M, Mendez-Franco J, Rambert FA, Fuxe K (1999) The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 20:346-356
54. Fischman MW, Johanson CE (1998) Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers. Behav Pharmacol 9:479-498
55. Fischman MW, Schuster CR, Renekov L, Shick JF, Krasnegor NA, Fennell W, Freedman DX (1976) Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 33:983-989
56. Fischman MW, Foltin RW, Nestadt G, Pearlson GD (1990) Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 253:760-770
57. Foltin RW, Fischman MW (1991) Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257:247-261
58. Foltin RW, Fischman MW (1992) Self-administration of cocaine by humans: choice between smoked and intravenous cocaine. J Pharmacol Exp Ther 261:841-849
59. Foltin RW, Fischman MW (1994) Effects of buprenorphine on the self-administration of cocaine by humans. Behav Pharmacol 5:79-89
60. Foltin RW, Fischman MW (1996) Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther 278:153-164
61. Foltin RW, Haney M (2004) Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav 78:93-101
62. Foltin RW, Ward AS, Collins ED, Haney M, Hart CL, Fischman MW (2003) The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans. Exp Clin Psychopharmacol 11:123-130
63. Gonzalez G, Oliveto A, Kosten TF (2002) Treatment of heroin (diamorphine) addiction: current approaches and future prospects. Drugs 62:1331-1343
64. Gorelick DA, Wilkins JN (2006) Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels. Drug Alcohol Depend 81:189-195
65. Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D, Bailey R (2000) Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmcol 20:305-310
66. Grabowski J, Shearer J, Merrill J, Negus SS (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439-1464
67. Grassi MC, Cioce AM, Giudici FD, Antonilli L, Nencini P (2007) Short-term efficacy of disulfiram or naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: a pilot study. Pharmacol Res 55:117-121
68. Greenwald M, Johanson CE, Bueller J, Chang Y, Moody DE, Kilbourn M, Koeppe R, Zubieta JK (2007) Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices. Biol Psychiatry 61:101-110
69. Griffiths RR, Wurster RM, Brady JV (1976) Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin. Pharmacol Rev 27:357-65
70. Gui-Hua C, Perry BD, Woolverton WL (1992) Effects of chronic SCH 23390 or acute EEDQ on the discriminative stimulus effects of SKF 38393. Pharmacol Biochem Behav 41:321-327
71. Haney M, Kosten TR (2005) Therapeutic vaccines for substance dependence. Drug Discov Today 2:65-69
72. Haney M, Foltin RW, Fischman MW (1998) Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology 137:15-24
73. Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999) Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143:102-110
74. Haney M, Ward AS, Foltin RW, Fischman MW (2001) Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology 155:330-337
75. Haney M, Hart CL, Foltin RW (2006) Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology 31:1814-1821
76. Harrigan SE, Downs DA (1978) Continuous intravenous naltrexone effects on morphine self-administration in rhesus monkeys. J Pharmacol Exp Ther 204:481-486
77. Harrington SE, Downs DA (1981) Pharmacological evaluation of narcotic antagonist delivery systems in rhesus monkeys. In: RE Willette, G Burnett (eds) Naltrexone, NIDA Research Monograph 28, pp 77-100
78. Hart CL, Ward AS, Collins ED, Haney M, Foltin RW (2004) Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend 73:279-287
79. Hart CL, Haney M, Collins ED, Rubin E, Foltin RW (2007a) Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses. Drug Alcohol Depend 86:274-277
80. Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW (2007b) Gabapentin does not reduce smoked cocaine self-administration: employment of a novel self-administration procedure. Behav Pharmacol 18:71-75
81. Hart CL, Haney M, Vosburg SK, Rubin E, Foltin RW (2008) Human smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology (in press)
82. Hatsukami DK, Pentel PR, Glass J, Nelson R, Brauer LH, Crosby R, Hanson K (1994) Methodological issues in the administration of multiple doses of smoked cocaine-base in humans. Pharmacol Biochem Behav 47:531-540
83. Hess EJ, Albers LJ, Le H, Creese I (1986) Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. J Pharmacol Exp Ther 238:846-854
84. Higgins ST, Bickel WK, Hughes JR (1994) Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 55:179-187
85. Howell LL, Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258:178-185
86. Hubner CB, Moreton JE (1991) Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105:151-156
87. Jackson DM, Westlind-Danielsson A (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64:291-370
88. Jasinski DR (2000) An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol 14:53-60
89. Jasinksi DR, Pervnick JS, Griffith JD (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psychiatry 35:601-616
90. Johanson CE, Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkeys. Bull Narc 30:43-54
91. Johnson RE, Chutuape MA, Strain EC, Walksh SL, Stitzer ML, Bigelow GE (2000) A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 343:1290-1297
92. Jones BE, Prada JA (1975) Drug-seeking behavior during methadone maintenance. Psychopharmacologia 41:7-10
93. Jones BE, Prada JA (1977) Effects of methadone and morphine on drug-seeking behavior in the dog. Psychopharmacologia 54:109-112
94. Kampman KM, Dackis C, Lynch KG, Pettinati H, Tirado C, Gariti P, Sparkman T, Atzram M, O'Brien CP (2006) A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend 85:129-137
95. Kantak KM (2003) Vaccines against drugs of abuse: a viable treatment option? Drugs 63:341-352
96. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93-96
97. Kleber HD (1985) Naltrexone. J Subst Abuse Treat 2:117-112
98. Kleven MS, Woolverton WL (1990) Effects of continuous infusions of SCH 23390 on cocaine- or food-maintained behavior in rhesus monkeys. Behav Pharmacol 1:365-373
99. Koob GF, Pettit HO, Ettenberg A, Bloom FE (1984) Effects of opiate antagonists and their quaternary derivatives on heroin self-administration in the rat. J Pharmacol Exp Ther 229:481-486
100. Korotkova TM, Klyuch BP, Ponomarenko AA, Lin JS, Haas HL, Sergeeva OA (2007) Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors. Neuropharmacology 52:626-633
101. Kosten TA (1997) Enhanced neurobehavioral effects of cocaine with chronic neuroleptic exposure in rats. Schizophr Bull 23:203-213
102. Kosten TA, DeCaprio JL, Nestler EJ (1996) Long-term haloperidol administration enhances and short-term administration attenuates the behavioral effects of cocaine in a place conditioning procedure. Psychopharmacology 128:304-312
103. Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Jack L, Fox B (2002) Human therapeutic cocaine vaccine: safety and immunogenicity. Vaccine 20:1196-1204
104. Lile JA, Nader MA (2003) The abuse liability and therapeutic potential of drugs evaluated for cocaine addiction as predicted by animal models. Current Neuropharmacology 1:21-46
105. Lile JA, Stoops WW, Vansickel AR, Glaser PEA, Hays LR, Rush CR (2005) Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine in humans. Neuropsychopharmacology 30:2103-2114
106. Lukas SE, Brady JV, Griffiths RR (1986) Comparison of opioid self-injection and disruption of schedule-controlled performance in the baboon. J Pharmacol Exp Ther 238:924-931
107. Madras BK, Fahey MA, Bergman J, Canfield DR, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. I. [3H] cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141
108. Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ (2006) Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319:561-569
109. Malcolm R, Kajdasz DK, Herron J, Anton RF, Brady KT (2000) A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend 60:161-168
110. Malcolm R, Swayngim K, Donovan JL, DeVane CL, Elkashef A, Chiang N, Khan R, Mojsiak J, Myrick DL, Hedden S, Cochran K, Woolson RF (2006) Modafinil and cocaine interactions. Am J Drug Alcohol Abuse 32:577-587
111. Marlatt GA (1996) Models of relapse and relapse prevention: a commentary. Exp Clin Psychopharmacol 4:55-60
112. Marsch LA, Bickel WK, Badger GJ, Jacobs EA (2005) Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing. Drug Alcohol Depend 77:195-204
113. Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR (2005) Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol Psychiatry 58:158-164
114. McCance-Katz E, Kosten TA, Kosten TR (2001) Going from the bedside back to the bench with ecopipam: a new strategy for cocaine pharmacotherapy development. Psychopharmacology 155:327-329
115. McGregor A, Roberts DCS (1993) Dopaminiergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res 624:245-252
116. Mello NK, Mendelson JH (1980) Buprenorphine suppresses heroin use by heroin addicts. Science 207:657-659
117. Mello NK, Mendelson JH (1985) Behavioral pharmacology of buprenorphine. Drug Alcohol Depend 14:283-303
118. Mello MK, Negus SS (1996) Preclinical evaluation of pharmocotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424
119. Mello NK, Negus SS (1998) The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combinations and heroin alone by rhesus monkeys. J Pharmacol Exp Ther 285:444-456
120. Mello NK, Mendelson JH, Kuehnle JC, Sellers MS (1981a) Operant analysis of human heroin self-administration and the effects of naltrexone. J Pharmacol Exp Ther 216:45-54
121. Mello NK, Bree MP, Mendelson JH (1981b) Buprenorphine self-administration by rhesus monkey. Pharmacol Biochem Behav 15:215-225
122. Mello NK, Mendelson JH, Kuehnle JC (1982) Buprenorphine effects on human heroin self-administration: an operant analysis. J Pharmacol Exp Ther 223:30-39
123. Mello NK, Bree MP, Mendelson JH (1983) Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J Pharmacol Exp Ther 225:378-386
124. Mello NK, Lukas SE, Bree MP, Mendelson JH (1988) Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys. Drug Alcohol Depend 21:81-97
125. Meyer RE, Mirin SM (1979) The heroin stimulus: implication for a theory of addiction. Plenum, New York
126. Mignot E, Nishino S, Guilleminault C, Dement WC (1994) Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17:436-437
127. Myrick H, Malcolm R, Taylor B, LaRowe S (2004) Modafinil: preclinical, clinical, and post-marketing surveillance-a review of abuse liability issues. Ann Clin Psychiatry 16:101-109
128. Nader MA, Woolverton WL (1992) Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure. Psychopharmacology 105:169-174
129. Nann-Vernotica E, Donny EC, Bigelow GE, Walsh SL (2001) Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology 155:338-347
130. Negus SS (2006) Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther 317:711-723
131. Negus SS, Mello NK (2003) Effects of chronic d-amphetamine treatment on cocaine and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend 70:39-52
132. Newton TF, Kalechstein A, Beckson M, Bartzokis G, Bridge TP, Ling W (1999) Effects of selegiline pretreatment on response to experimental cocaine administration. Psychiatry Res 87:101-106
133. Obadia Y, Perrin V, Feroni I, Vlahov D, Moatti J-P (2001) Injecting misuse of buprenorphine among French drug users. Addiction 96:267-272
134. O'Brien CP, Greenstein RA, Mintz J, Woody GE (1975) Clinical experience with naltrexone. Am J Drug Alcohol Abuse 2:365-377
135. Pickens R (1968) Self-administration of stimulants by rats. Int J Addict 3:215-221
136. Platt DM, Rowlett JK, Spealman RD (2001) Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys. Psychopharmacology 157:208-216
137. Platt DM, Rowlett JK, Spealman RD (2002) Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 163:265-282
138. Preston KL, Sullivan JT, Strain EC, Bigelow GE (1992) Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther 262:279-291
139. Pulvirenti L, Balducci C, Piercy M, Koob GF (1998) Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. J Pharmacol Exp Ther 286:1231-1238
140. Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11
141. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Washington, DC) 237:1219-1223
142. Romach MK, Flue P, Kampman K, Kaplan HL, Somer GR, Poole S, Clarke L, Coffin V, Cornish J, O'Brien CP, Sellers EM (1999) Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166). Arch Gen Psychiatry 56:1101-1106
143. Rowlett JK, Wilcox KM, Woolverton WL (1998) Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone. J Pharmacol Exp Ther 286:61-69
144. Rush CR, Kelly TH, Hays LR, Baker RW, Wooten AF (2002a) Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol 13:105-115
145. Rush CR, Kelly TH, Hays LR, Wooten AF (2002b) Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug Alcohol Depend 67:311-322
146. Schecter A (1980) The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone. Am J Drug Alcohol Abuse 7:1-18
147. Schindler CW, Panlilio LV, Goldberg SR (2002) Second-order schedules of drug self-administration in animals. Psychopharmacology 63:327-344
148. Schuster CR, Johanson CE (1974) The use of animal models for the study of drug abuse. In: Gibbins RJ, Israel Y, Kalant H, Popham R, Schmidt W, Smart RG (eds) Research advances in alcohol and drug problems, vol 1. Wiley, New York, pp 1-31
149. Shoptaw S, Yang X, Rotheram-Fuller EJ, Hsieh YC, Kintaudi PC, Charuvastra VC, Ling W (2003) Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry 64:1440-1448
150. Sofuoglu M, Pentel PR, Bliss RL, Goldman AI, Hatsukami DK (1999) Effects of phenytoin on cocaine self-administration in humans. Drug Alcohol Depend 53:273-275
151. Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A (2003) Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav 75:801-808
152. Spealman RD, Goldberg SR (1978) Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol 8:313-339
153. Spealman RD, Bergman J, Madras BK, Kamien JB, Melia KF (1992) Role of D1 and D2 dopamine receptors in the behavioral effects of cocaine. Neurochem Int 20:147S-152S
154. Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV (1999) Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64:327-336
155. Spragg SD (1940) Morphine addiction in chimpanzees. Comparative Psychology Monographs 15:1-132
156. Stafford D, LeSage MG, Glowa JR (1998) Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology 139:169-184
157. Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR (2005) Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology 182:186-193
158. Strain EC, Bigelow GE, Liebson IA, Stitzer ML (1999) Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 281:1000-1005
159. Sullivan MA, Vosburg SK, Comer SD (2006) Depot naltrexone: antagonism of the reinforcing, subjective and physiological effects of heroin. Psychopharmacology 189:37-46
160. Thompson T, Schuster CR (1964) Morphine self-administration, food reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacology 5:87-94
161. Tiihonen J, Kuoppasalmi K, Föhr J, Tuomola P, Kuikanmäki O, Vorma H, Sokero P, Haukka J, Meririnne E (2007) A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry 164:160-162
162. Vaccheri A, Dall'Olio R, Gandolfi O, Roncada P, Montanaro N (1987) Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390. Psychopharmacology 91:394-396
163. Vidal-Trecan G, Verscon I, Nabet N, Boissonnas A (2003) Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France. Drug Alcohol Depend 69:175-181
164. Walsh SL, Eissenberg T (2003) The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend 70:S13-S27
165. Walsh SL, Geter Douglas B, Strain EC, Bigelow GE (2001) Enadoline and butorphanol: evaluation of k-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther 299:147-158
166. Weeks JR (1962) Experimental morphine addiction: method for automatic intravenous injection in unrestrained rats. Science 138:143-144
167. Weeks JR, Collins RJ (1976) Changes in morphine self-administration in rats induced by prostaglandin E1 and naloxone. Prostaglandins 12:11-19
168. Weerts EM, Fantegrossi WE, Goodwin AK (2007) The value of nonhuman primates in drug abuse research. Exp Clin Psychopharmacol 15:309-327
169. White FJ, Joshi A, Koeltzow TE, Hu XT (1998) Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology 18:26-40
170. Winger G (1994) Dopamine antagonist effects on behavior maintained by cocaine and alfentanil in rhesus monkeys. Behav Pharmacol 5:141-152
171. Winger G, Woods JH (1996) Effects of buprenorphine on behaviour maintained by heroin and alfentanil in rhesus monkeys. Behav Pharmacol 7:155-159
172. Winger G, Woods JH (2001) The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug Alcohol Depend 62:181-189
173. Winger G, Skjoldager P, Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261:311-317
174. Woods JH, Schuster CR (1968) Reinforcement properties of morphine, cocaine and SPA as a function of unit dose. Internat J Addict 3:231-237
175. Woolverton WL (1986) Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav 24:531-535
176. Woolverton WL, Anderson KG (2006) Effects of delay to reinforcement on the choice between cocaine and food in rhesus monkeys. Psychopharmacology 186:99-106
177. Woolverton WL, Balster RL (1981) Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food. Drug Alcohol Depend 8:69-78
178. Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193-200
179. Woolverton WL, Virus RM (1989) The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol Biochem Behav 32:691-697
180. Woolverton WL, English JA, Weed MR (1997) Choice between cocaine and food in a discrete-trials procedure in monkeys: a unit price analysis. Psychopharmacology 133:269-274
181. Young AM, Stephens KR, Hein DW, Woods JH (1984) Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. J Pharmacol Exp Ther 229:118-126